论文部分内容阅读
[目的]探讨痰热清注射液辅助西药治疗急性支气管炎的临床疗效。[方法]选择2011年4月至2012年5月我院收治的78例急性支气管炎患者,随机分为治疗组41例和对照组37例,所有患者均使用头孢哌酮钠舒巴坦钠常规治疗,治疗组在此基础上使用痰热清注射液,比较两组患者的疗效,症状消失时间和住院时间。[结果]治疗组患者总有效率为97.50%,显著高于对照组的83.80%;治疗组各项症状消失时间和住院时间也比对照组少;以上差异均有统计学意义(P<0.05)。[结论]痰热清注射液辅助西药治疗急性支气管炎疗效显著,值得临床推广应用。
[Objective] To investigate the clinical efficacy of Tanreqing Injection in assisting western medicine in the treatment of acute bronchitis. [Methods] A total of 78 patients with acute bronchitis treated in our hospital from April 2011 to May 2012 were randomly divided into treatment group (n = 41) and control group (n = 37). All patients were treated with cefoperazone sodium and sulbactam sodium, On the basis of this group, Tanreqing Injection was used to compare the curative effect, disappearance of symptoms and length of stay in both groups. [Results] The total effective rate in the treatment group was 97.50%, which was significantly higher than that in the control group (83.80%). The disappearance time and hospitalization time of the symptoms in the treatment group were also less than those in the control group (all P <0.05) . [Conclusion] Phlegm-heat injection assisted western medicine in the treatment of acute bronchitis has significant curative effect, which is worthy of clinical application.